Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis. is a clinical trial[1].
Key Facts
- Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis. is in the country of United Kingdom[2].
- Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.'s instance of is recorded as clinical trial[3].
- Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.'s start time is recorded as +2008-02-29T00:00:00Z[4].
- Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.'s end time is recorded as +2008-05-31T00:00:00Z[5].
- Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.'s sponsor is recorded as University of Nottingham[6].
- Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.'s main subject is recorded as sclerosis[7].
- Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.'s main subject is recorded as multiple sclerosis[8].
- Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.'s number of participants is recorded as {'unit': '1', 'amount': '+0'}[9].
- Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.'s title is recorded as Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.[10].
- Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.'s short name is recorded as WIRMS-1[11].
- Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[12].
- Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.'s ClinicalTrials.gov ID is recorded as NCT00630383[13].
- Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.'s maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+60'}[14].
- Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.'s clinical trial phase is recorded as phase II clinical trial[15].
- Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.'s research site is recorded as Nottingham University Hospitals NHS Trust[16].
- Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.'s study type is recorded as interventional study[17].